Rheonix, Inc. Announces Patent Issuance and Allowance of Patent Applications for Its Molecular Diagnostic Platform

Published: Jun 03, 2011

Rheonix, Inc., developer of the Rheonix CARD® system that provides a powerful microfluidic platform for the evolving molecular diagnostics industry, announced that on June 14, 2011 the U.S. Patent and Trademark Office will issue Patent Number 7,959,875, "Microfluidic Chips and Assay Systems,” and on April 13, 2011 it allowed Patent Application Number 11/594,444, “Microfluidic Systems,” to the Company. These patents, together with existing intellectual property, complete coverage for the Company’s core device and its instrument control systems, which provide a versatile platform for the development of commercially viable diagnostic products.

Back to news